The Imprinting Group at the School of Chemical Engineering and Analytical Sciences, The University of Manchester is seeking an enthusiastic and creative candidate to work on a PhD project on Downstream Processing of Pharmaceuticals.

The (bio)pharmaceutical industry is currently experiencing considerable technology maturation and is growing significantly: the global market was valued at $149 billion in 2010 and is expected to reach $239 billion by 2015. Downstream processing can account for as high as 90% of the total manufacturing costs. Conventional downstream processing technologies suffer low selectivity and require several stages to achieve desired purity, leading to high product loss and solvent consumption.

Manufacturers of (bio)pharmaceuticals want to intensify their downstream processes to achieve high purity without compromising yield. The overall concept of the project is to make important paradigm shifts in the downstream processing of (bio)pharmaceuticals by turning the cutting edge imprinting methodology into a readily applicable industrial technology.